Valuation Comparison

Showing 3714 articles
Business

STERIS Stock: A 20% Surge Leaves Investors Wondering If the Rally Has Run Its Course

STERIS plc's shares have climbed over 20% in the past year, prompting a critical valuation debate. While a discounted cash flow model suggests the stock is fairly priced, its elevated P/E ratio compared to industry peers raises questions about its current premium. We examine the metrics and investor narratives shaping the outlook for this healthcare infrastructure leader.